Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Proto Labs Inc (PRLB)
|
Add to portfolio |
|
|
|
| Price: |
$54.13
| | Metrics |
| OS: |
26.1
|
M
| |
|
|
| Market cap: |
$1.41
|
B
| |
|
|
|
Net cash:
|
$103
|
M
| |
$3.94
|
per share
|
|
EV:
|
$1.31
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$73.7
|
M
| |
17.8
|
x EV/EBITDA
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 488.1 | 434.4 | 458.7 | 445.6 | 344.5 | 298.1 | 264.1 | 209.6 |
| Revenue growth | 12.4% | -5.3% | 2.9% | 29.3% | 15.6% | 12.9% | 26.0% | 28.5% |
| Cost of goods sold | 265.4 | 216.6 | 223.4 | 206.9 | 150.6 | 131.1 | 109.7 | 81.2 |
| Gross profit | 222.7 | 217.8 | 235.3 | 238.7 | 193.8 | 166.9 | 154.4 | 128.4 |
| Gross margin | 45.6% | 50.1% | 51.3% | 53.6% | 56.3% | 56.0% | 58.5% | 61.3% |
| Sales and marketing | 82.2 | 69.3 | 73.0 | 68.5 | 56.9 | 46.1 | 39.2 | 29.1 |
| Research and development | 44.2 | 36.9 | 32.7 | 28.7 | 23.6 | 22.4 | 18.4 | 16.6 |
| General and administrative | 55.9 | 51.7 | 49.8 | 52.5 | 41.2 | 36.7 | 29.7 | 22.1 |
| EBITA | 46.5 | 62.8 | 83.4 | 92.1 | 72.7 | 62.5 | 67.8 | 61.0 |
| EBITA margin | 9.5% | 14.5% | 18.2% | 20.7% | 21.1% | 21.0% | 25.7% | 29.1% |
| Amortization of intangibles | 6.2 | 3.0 | 3.5 | 3.2 | 0.5 | 0.7 | 0.7 | 0.5 |
| EBIT | 40.3 | 59.8 | 79.9 | 88.9 | 72.2 | 61.8 | 67.1 | 60.5 |
| EBIT margin | 8.3% | 13.8% | 17.4% | 20.0% | 21.0% | 20.7% | 25.4% | 28.9% |
| Pre-tax income | 40.2 | 62.9 | 81.2 | 91.7 | 74.4 | 64.2 | 67.9 | 60.5 |
| Income taxes | 6.8 | 12.1 | 17.5 | 15.1 | 22.7 | 21.5 | 21.3 | 18.9 |
| Tax rate | 17.0% | 19.2% | 21.6% | 16.4% | 30.4% | 33.5% | 31.5% | 31.2% |
| Net income | 33.4 | 50.9 | 63.7 | 76.6 | 51.8 | 42.7 | 46.5 | 41.6 |
| Net margin | 6.8% | 11.7% | 13.9% | 17.2% | 15.0% | 14.3% | 17.6% | 19.9% |
| |
| Diluted EPS | $1.21 | $1.89 | $2.35 | $2.81 | $1.93 | $1.61 | $1.77 | $1.60 |
| Shares outstanding (diluted) | 27.7 | 26.9 | 27.0 | 27.3 | 26.8 | 26.6 | 26.3 | 26.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|